Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04431635 |
|---|---|
| Brief Title: | Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma |
| First Submitted : | June 11, 2020 |
| First Submitted that Met QC Criteria : | June 12, 2020 |
| First Posted : | June 16, 2020 |
| Last Update Submitted that Met QC Criteria : | November 13, 2020 |
| Last Update Posted : | November 16, 2020 |